why am i gaining weight on semaglutide Gain Ozempic? Causes and Solutions Weight Gain on Ozempic: Causes

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated consistent weight loss across multiple clinical trials

This reduces risks linked to lean-mass loss and promotes healthier long-term outcomes

It is important to note that GLP-1 receptor agonists are not currently licensed for the treatment of rheumatoid arthritis or other inflammatory conditions in the UK

Key disclosures from company terms include: MEDVi states it does not directly provide medical or pharmacy services Payment does not guarantee the writing or dispensing of a prescription The site identifies itself as "an advertisement for services and not any specific medication" OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients Entity Structure According to MEDVi's terms of use: "MEDVi does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." MEDVi, LLC: Technology platform providing intake coordination, customer service, and payment processing OpenLoop Health: According to company disclosures, provides the network of licensed medical providers who conduct evaluations and make prescribing decisions Partner compounding pharmacies: According to the website, MEDVi partners with "multiple USA certified pharmacies" Pricing (As of December 26, 2025) Cost considerations are separate from medical appropriateness and should not influence prescribing decisions

This page presents investigational context in a structured format suitable for research-focused audiences

L- , , , , ,